Pages

Monday, 3 December 2018

GlaxoSmithKline to spend $5.1B on cancer drugmaker Tesaro


GlaxoSmithKline to spend $5.1B on cancer drugmaker Tesaro



Shares of Tesaro soared early Monday after GlaxoSmithKline said it would pay about $5.1 billion in cash to buy the cancer drugmaker.

No comments:

Post a Comment